Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wag! Group Co

0.1692
-0.0620-26.82%
Volume:13.37M
Turnover:2.36M
Market Cap:8.59M
PE:-0.44
High:0.2050
Open:0.1969
Low:0.1609
Close:0.2312
Loading ...

Wag! Group Co. Conducted Annual Meeting, Voted on Key Proposals

Reuters
·
19 Jun

National Bank Sticks to Their Buy Rating for Pet Valu Holdings Ltd. (PET)

TIPRANKS
·
05 Jun

Clarity Says Imaging Product Shows Superior Results in Phase 2 Trial Versus Standard of Care; Shares Jump 3%

MT Newswires Live
·
05 Jun

GE Healthcare Says Updated NCCN Guidelines Recommend Use of FES PET Imaging for Breast Cancer

MT Newswires Live
·
30 May

Dongcheng Pharmaceutical Gets Marketing Approval for PET Imaging Agent

MT Newswires Live
·
28 May

Carlit Unit JC Bottling Secures Energy Conservation Subsidy for PET Line Upgrade

MT Newswires Live
·
26 May

Wag Group Q1 EPS $(0.10) Misses $(0.07) Estimate, Sales $15.16M Miss $19.30M Estimate

Benzinga
·
12 May

Press Release: Wag! Reports First Quarter 2025 Results

Dow Jones
·
12 May

Malaysian Shares Rebound Midweek Tracking Gains of Regional Markets

MT Newswires Live
·
07 May

Barclays Keeps Their Buy Rating on Pet Valu Holdings Ltd. (PET)

TIPRANKS
·
07 May

Wag! To Report First Quarter 2025 Financial Results on May 12, 2025

GlobeNewswire
·
02 May

Lantheus Holdings (NasdaqGM:LNTH) Advances Alzheimer's PET Diagnostic With Successful Trial Results

Simply Wall St.
·
02 May

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

GlobeNewswire
·
30 Apr

RBC Capital Keeps Their Buy Rating on Pet Valu Holdings Ltd. (PET)

TIPRANKS
·
29 Apr

Telix Pharmaceuticals Secures Marketing Authorization for Prostate Cancer Imaging Agent in France

MT Newswires Live
·
29 Apr

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

GlobeNewswire
·
29 Apr

Wall Street Set to Open Lower Friday Amid Slew of Earnings Reports

MT Newswires Live
·
25 Apr

Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano

PR Newswire
·
17 Apr

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

GlobeNewswire
·
02 Apr

Telix Says First Patient Administered Drug Candidate in Trial for Soft Tissue Sarcoma

MT Newswires Live
·
02 Apr